Bionow’s inaugural BioInsight Conference combines innovation and collaboration across Scotland and the Northern UK

Bionow Event
Bionow News

Bionow's first BioInsight Conference brought together delegates from across Scotland and the wider UK at the Health Innovation Hub in Glasgow to explore the ideas, technologies and collaborations shaping the future of life sciences. The event welcomed 100 researchers, industry leaders, innovators, investors and support organisations for a day of discussion, networking and knowledge sharing focused on translating innovation into impact.

BioInsight created opportunities for attendees to exchange ideas, build new connections and examine the trends influencing the future of innovation and commercialisation. While the conference highlighted the strengths and opportunities within Scotland's thriving life sciences community, discussions also reflected the increasingly connected nature of the Northern UK ecosystem and the importance of collaboration across regions.

The agenda featured keynote presentations, panel discussions and contributions from organisations spanning industry, academia, healthcare and the wider innovation landscape. Throughout the day, speakers explored topics including technology development, investment, commercialisation and the partnerships required to bring new innovations to market and deliver meaningful impact.

Two keynote speakers, former Scottish Government Minister for Business, Richard Lochhead, and Poonam Malik, Founder & CEO of PM InnoVatures Ltd, presented to the delegates on the day.

Richard Lochhead reflected on Scotland's long-standing reputation as a nation of innovation, highlighting how life-changing and world-changing ideas have emerged from the country throughout its history. He emphasised the strength of Scotland's life sciences sector, describing it as a substantial and sophisticated ecosystem supported by ambitious companies, entrepreneurs and researchers. Looking to the future, he spoke about the discoveries currently being made across Scotland that have the potential to create transformative impact in ways that cannot yet be imagined.

The presentation also highlighted practical measures being taken to support the sector's continued growth, including a £35 million fund to develop new laboratory space. He stressed the importance of international collaboration and market access, encouraging Scottish companies to look outward and seize global opportunities, while reaffirming Scotland's commitment to helping businesses build connections and open doors around the world.

Poonam Malik's keynote, Paths to the Dreamland, brought a personal perspective on innovation, entrepreneurship and international growth. Drawing on her experiences as a founder, investor, commercial strategist, board advisor and ecosystem leader, Poonam shared reflections from her journey of building bridges between different innovation ecosystems across the world.

The presentation also explored the opportunities and challenges facing founders and growing businesses, offering insight into what is already working well within Scotland's innovation landscape and where further progress could be made, encouraging delegates to consider how stronger connections between research, investment and commercialisation can help unlock greater growth opportunities, while positioning Scotland as a leading destination for innovation, investment and internationally successful businesses.

A related theme that surfaced throughout the conference was the need to raise the international profile of the region's life sciences sector. During the opening panel discussion on scaling, speakers reflected on the talent, innovation and ambition already present across Scotland and the wider Northern UK, while highlighting the importance of doing more to showcase these strengths globally. One memorable remark, "No Scotland, No Scaling", captured the discussion and the belief that greater visibility and stronger international positioning will be key to unlocking future growth, investment and collaboration opportunities.

The agenda also showcased how life sciences companies from across the region are translating cutting-edge research into practical healthcare solutions. Across the sessions, several other common themes emerged, including the use of advanced data analytics and artificial intelligence to unlock new biological insights, the development of innovative approaches to address significant unmet medical needs, and the continued importance of investment in translational science to move discoveries from the laboratory towards real-world application.

The presentations also highlighted the growing convergence of biology, data science, engineering and digital technologies across the Northern UK life sciences landscape. Discussions explored how predictive technologies can support faster and more informed decision-making, how novel therapeutic and diagnostic approaches are being developed to tackle complex healthcare challenges, and how innovation can improve the efficiency, scalability and accessibility of future healthcare solutions. Collectively, the case studies demonstrated the value of collaboration across industry, academia, healthcare and investment communities in driving growth, attracting global interest and delivering meaningful impact for patients worldwide.

Bionow’s Executive Director of Business Development, Stella James, commented: “One of the most rewarding aspects of BioInsight was seeing people from across the ecosystem come together with a genuine willingness to collaborate and learn from one another. The energy throughout the day reflected the ambition of the life sciences sector across Scotland and the North, and we are proud to have provided a platform for those conversations to happen. We look forward to seeing many of the ideas and connections formed at BioInsight develop into future partnerships and innovations.

The 2026 BioInsight conference was sponsored by Kadans Science Partner and Equans Sci-Tech.